Tumor in the Crossfire: Inhibiting TGF-β to Enhance Cancer Immunotherapy
Tumor in the Crossfire: Inhibiting TGF-β to Enhance Cancer Immunotherapy
About this item
Full title
Author / Creator
Publisher
Cham: Springer International Publishing
Journal title
Language
English
Formats
Publication information
Publisher
Cham: Springer International Publishing
Subjects
More information
Scope and Contents
Contents
Cancer immunotherapy using monoclonal antibodies targeting immune checkpoints has undoubtedly revolutionized the cancer treatment landscape in the last decade. Immune checkpoint inhibitors can elicit long-lasting, previously unheard-of responses in a number of tumor entities. Yet, even in such tumors as metastatic melanoma and non-small cell-lung c...
Alternative Titles
Full title
Tumor in the Crossfire: Inhibiting TGF-β to Enhance Cancer Immunotherapy
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8986721
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8986721
Other Identifiers
ISSN
1173-8804
E-ISSN
1179-190X
DOI
10.1007/s40259-022-00521-1
